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Summal"y 
Peptide fragments of foreign and self-proteins are of great immunologic importance as their binding 
to major histocompatibility complex (MHC) class I or II molecules makes an interaction with 
a corresponding T cell receptor possible. Recently, allele-specific peptide sequence motifs proved 
to be responsible for MHC binding, no matter whether self- or non-self-antigens were involved. 
Up to now, all investigated human class II-associated peptides were derived from foreign antigenic 
proteins. Therefore, we undertook sequence and binding analyses with a 16-met self-peptide (SP3) 
that has been eluted from HLA-DR1.  Here we demonstrate, by synthetic polyalanine-based 13- 
met analogues of SP3, that two bulky hydrophobic anchor residues with relative spacing i, i+ 8 
are sufficient for high affinity binding. This is consistent with the hydrophobic i, i+8 binding 
pattern recently found for DR-restricted T  cell epitopes. Nevertheless, highly helical alanine- 
based design peptides with anchor spacing i, i+ 9 exhibit maximal affinity, whereas replacement 
of alanine by helix destabilizing proline abrogates binding. Thus, a two-residue contact motif 
is the common minimal requirement of self- and foreign peptides for high affinity anchoring 
to HLA-DR1.  In contrast to class I, the anchor spacing of DRl-associated peptides seems to 
bear  some variability due to conformational diversity. 
T  lymphocyte Ag receptors recognize complexes built up 
by class I or class II MHC molecules and peptide frag- 
ments of processed antigens on the surface of an APC (1). 
There is growing evidence that the discrimination of self from 
non-self cannot be the task of an APC since the cellular pro- 
cessing and MHC loading machinery is not able to distin- 
guish self- from non-self-peptide antigens (2). Tolerance versus 
self seems to be due to negative selection of anti-self-T cells 
in the thymus and clonal anergy in the periphery (3, 4). En- 
dogenously processed self-peptides, therefore, play a central 
role in several instances: (a) thymic MHC-bound self-peptides 
are involved in positive and negative selection of the T  cell 
repertoire (5); (b) the stability of MHC/self-peptide complexes 
determines the number of MHC molecules available for for- 
eign peptide antigens (6); and (c) a considerable portion of 
alloreactive T  cell clones recognize MHCAelf-peptide com- 
plexes (7). Sequence analyses of self-peptides from murine as 
well as human class I have shown that all of them are octa- 
or nonamers being fixed to the MHC  molecule by allele- 
specific anchor residues (8, 9). High-resolution structural anal- 
yses revealed that HLA-B27 binds nonamer self-peptides in 
extended conformation (10). In contrast to these class I results, 
self-peptides released from murine class II proved to be 13-17 
amino acids long having no sequence pattern comparable to 
class  I  self-peptides (11). 
To unravel the corresponding human class II rules, we pre- 
pared a self-peptide mixture ehted from detergent-sohbilized 
HLA-DR1. Our earlier results rationalized that DR1 mole- 
cules bear hydrophobic pockets that are filled upon peptide 
binding (12).  This might occur by one to three apolar side 
chains that have been found with most of the DR-restricted 
foreign peptides  (13-18),  although  the  motifs defined by 
different groups applying different approaches are not uni- 
form. Our findings presented here do strongly favor a hydro- 
phobic motif consisting of two aromatic or aliphatic anchors, 
the spacing of which is not constant in all peptides, probably 
due to some folding flexibility of the peptide backbone. 
Materials  and Methods 
Cells.  EBV-transformed homozygous and consanguineous cell 
line WT-100 was used as a source for the isolation of HLA-DR1 
and -DQw5 molecules. The cell line was maintained in vitro at 
37~  in 5% CO2 by culture in RPMI 1640 (Gibco Laboratories, 
Grand Island, NY), containing 5% heat-inactivated  FCS, 2 mM 
glutamine, and antibiotics. 
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resulting homogenate prepared for affinity chromatography with 
mAbs L243 (anti-DR) (19) and TO22 (anti-DQ) (20), essentially 
as described dsewhere (12). 
Preparation of Sel.fipeptides.  Endogenous peptides were released 
as previously described (12). The self-peptide pool and the three 
subpools SP1-SP3 were collected and dried by lyophilization. 
Sequence Analyses.  The self-peptide  pool of 400 ~g solubilized 
HLA-DR1 and the subpools SP1-SP3 were lyophilized and sub- 
jected to sequencing by Edman degradation. It was performed in 
a  pulsed-liquid  sequencer  (477A) equipped  with  an  on-line 
phenylthiohydantoin (FrH) amino acid analyzer (120 A; Applied 
Biosystems, Inc., Foster City, CA). Glass-fiber filters were coated 
with 1 rag BioBrene Plus (Applied Biosystems, Inc.). 
Peptide Synthesis.  SP3 and IM(18-29) and all analogues were 
synthesized  by continuous flow solid-phase peptide synthesis, using 
a  synthesizer (9050; MilliGen,  Eschborn,  Germany) based on 
Fmoc/Bu  ~  strategy. The polyalanine 13-mer peptides were synthe- 
sized by a multiple automatic peptide synthesizer system (Zinsser 
Analytic, Frankfurt,  Germany) based on Fmoc/Bu' strategy. Ly- 
sine was incorporated at the COOH terminus for means of solu- 
bility. All peptides were purified by HPI.C, and the identity was 
tested by ion-spray mass spectrometry. 
Fluorescence  Labeling.  NH2-terminal hbeling was performed as 
previously described (12). 
HPSEC  Peptide-binding Assay.  NHz-terminally  7-amino-4- 
methyl-coumarin-3-acetic acid (AMCA) fluorescently labeled pep- 
tides (200 and 300/zM) were coincubated with solubilized HLA- 
DR1 (3/~M) or with HLA-DQw5 (3/~M) for 48 h at 37~  in 
50 mM sodium acetate, 0.1% (wt/vol) CHAPS, pH 5.3, respec- 
tively. In the competition assay with polyahnine-based 13-mer an- 
alogues  of self-peptide SP3, NH2-terminally  labelled AMCA- 
SP3(1-16) (50/~M) was coincubated with DR1 (3/~M)  and the 
competitor peptide (100 and 200/dr  respectively,  under the same 
conditions as cited above. 25-/al aliquots of  each sample  were analyzed 
on a Superose I2 HR 10/30 column (Pharmacia Fine Chemicals, 
Piscataway, N]) equilibrated with the buffer cited above. High- 
performance size exclusion chromatography  (HPSEC) was per- 
formed as previously  descn~l (21). The AMCA fluorescence  signals 
eluting with HLA-DR or -DQ were recorded by an integrator (D- 
2500; Merck-Hitachi, Darmstadt,  Germany) and taken for cal- 
culating the amount of bound AMCA-hbded peptide. 
Results 
Pr r tio,, o/  Se 7, ti   HLA-nR1. Add treatment 
of detergent-soluble HLA-DR releases endogenously bound 
sdf-peptides that can be separated by reversed-phase HPLC 
(8). Since we started with highly purified DR heterodimers 
previously freed from unspediically or low affinity bound ma- 
terial by ukramembrane filtration (30-kD size exclusion), we 
can be sure that the acid-eluted components of the low mo- 
lecular mass fraction have been bound specifically and with 
high affinity.  Pig.  1 a  shows the HPLC chromatogram of 
the sdf-peptide fraction (SPP) eluted from DR1. The profile 
is dominated by a characteristic clustering of signals between 
5 and 19 min. Consistent with previous results from routine 
class I- and class II-derived peptide mixtures (8, 11), the SPF 
of HLA-DR1 dutes with 20-40% acetonitrile in the HPLC 
fractionation. 
Sequence Analysis of a Self-peptide Mixtur~  The self-peptide 
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Figure 1.  (a) Reverse-phase  HPLC profile of low molecular  mass frac- 
tion obtained after HCl-treatment  of solubilized HLA-DR1 detected  by 
absorbance at 214 nm. Fractions  from 5 to 19 rain (self-peptide  pool) de- 
void of subpools SFI-SP3 were pooled and subjected  to Edman sequence 
analysis. The dotted  line gives the percentage  of acetonittih  in the gradient. 
(b) Ik'verse-phase  HPI.C profile of synthetic  SP3(1-16), AILEFILAMA- 
QFSILKTD, detected  by absorbance at 214 nm. 
mixture, except SP1-SP3, was sequenced as a whole by con- 
ventional Edman degradation, as recently introduced (8). In 
contrast to the accumulation of certain amino acids in cer- 
tain sequencing cycles, found with class I peptide mixtures 
(8), in our case isoleudue, lenciue, and tyrosine simultane- 
ously exhibit predominant signals in cycle 1 as well as in cycle 
2. Alanine shows a weaker but prominent signal in cycle 1 
(data not shown). All other cycles do not contain any other 
significant maxima. Since there is no increase of any residue 
beyond cycle 16, the apparent maximal length of the majority 
of analyzed sdf-peptides is 16 residues. 
Sequence Analysis of SP3.  Sequencing of the sdf-peptide 
subpools SP1-SP3 led to a definitive sequence only in the case 
of SP3, whereas in SP1 and SP2 most of the sequencing cycles 
exhibited two to three amino acids (data not shown). The 
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Figure 2.  Affinity  and selectivity of binding of sdf-peptide SP3 com- 
pared with IM(18-29) in an HPSEC peptide-binding assay with NHz- 
terminally fluorescence  labeled peptides under saturating peptide concen- 
trations.  Relative fluorescence at  ham  450  nm  after coincubation of 
IM(18-29)) and DR1 (,), SP3(1-16) and DR1 (f-l), SP3(1-9) and DR1 
(A), and SP3(1-16) and DQw5 (A). 
sequence we got from SP3 is AILEFRAMAQFSRKTD. Its 
authenticity is confirmed by codution of the synthetic pep- 
tide (Fig. 1 b). SP3 is characterized by a hydrophobic NH2- 
terminal core and a COOH-terminal hydrophilic tail. The 
NH~.-terminal hydrophobic region is suited for an alignment 
according to the motif, recently deduced from a T cell assay 
with DR-restricted foreign T cell epitopes (18); thereafter, 
an aromatic or hydrophobic residue in position 1 (i), followed 
by S, T, A, V, I, L, P, C in position 6 (i+5), and another 
hydrophobic residue in position 9 (i+8), form a tentative DR 
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Figure 3.  Competition assay  with polyalanine~based 13-met derivatives 
of the DRl-associated self-peptide SP3. Given is the decrease of fluores- 
cence at hem 450 rim, measured in an HPSEC assay after coincubation 
of DR1, (AMCA)-SP3(1-16)  in presence or absence of the following in- 
hibitory  peptides: AL(A)10K (I-3), AL(A)9FK (short:  F10) (ll), 
AL(A)sFAK (short:  F9) (A),  F8 (A),  ALA(PA)~FAAK (0), F7 (0), 
F6 (O),  and  (A)gFAAK (0).  The  sequences  are  given  in  one-letter  code, 
respectively. 
motif. In our SP3 sequence, very similarly, Leu-3 and Phe-ll 
obey the spacing rule i, i+8, and may function as anchors 
relevant for binding to DR1. In addition, the hydrophobic 
core region is comparable with the DRl-restricted T cell epi- 
tope influenza matrix peptide IM(18-29)  by its high helical 
propensity,  as previously proposed  for IM(18-29)  (14, 16). 
The binding capacities of SP3 and IM(18-29), both exhibiting 
the i, i+8 motif, were compared in a recently introduced 
HPSEC binding assay (21). The NH2-terminally fluorescei- 
Table  1.  Alignment  of DR1-restricted T  Cell Epitopes and SP3 
T  cell epitope*  Protein  source* 
K  K  I  AKME  KA  S  S  VF 
E  VWREE  AYHAA 
QY  I  KAN  S  KF  I  G  I  T 
E  ALVRQG  L  AKVA 
RVKRGL  TVAVAG 
A  KLAK  LAGGVAV  I  K 
G  P  LKA  EI  AQRL  E 
P  KYVKQNT  L  KLA  T 
A  I  L  E  F  RAMAQF  S  RKT 
i  i+8 
D 
Circumsporozoite protein  (381-393) 
Ragweed (51-61) 
Tetanus  toxin (830-842) 
Ribonuclease (101-112) 
M. tuberculosis (3-14) 
M. Ieprae (65  kD)  (412-425) 
Influenza matrix protein  (18-29) 
Influenza hemagglutinin (307-319) 
Self-peptide  SP3 
Relative  anchor position 
The self-peptide sequence of  SP3 was aligned according  to the experimentally verified anchor spacing  i, i + 8 of influenza matrix peptide (18-29) (14, 18). 
* The sequences of the DRl-restricted  T cell epitopes were aligned according to the NH2-terminal bulky aromatic or aliphatic residue that is rele- 
vant for binding as recently described (12, 18). 
r See references 14 and 22 for a complete list of references. 
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as evidenced by a threefold binding capacity compared with 
IM(18-29) (Fig. 2). An 80% smaller signal upon coincuba- 
tion with HLA-DQw5 proves isotype-specific  binding of 
SP3(1-16). The same reduction in affinity is observed with 
the COOH-terminally truncated derivative SP3(1-9).  This 
result reconfirms the importance of the NH2-terminal half, 
but simultaneously implicates other contact sites beyond po- 
sition 9 crucial for high affinity binding. According to the 
postulated motif, Phe-11 could play this role. 
Competition Assay with SP3-based Polyalanine Design Pep- 
tides.  To answer the question whether Phe-ll is the COOH- 
terminal anchor of SP3, we created polyalanine-based 13-met 
analogues of SP3 and tested them in an HPSEC competition 
assay with AMCA-labded SP3(1-16) (Fig. 3). In alignment 
to IM(18-29), we chose Leu-3 as the NH2-terminal anchor 
and  shortened the  peptide by  the  NH2-terminal  alanine 
(Table 1). The resulting peptides with Leu at position 2 and 
Phe, varying from position 12 to 8, proved to be powerful 
competitors, as already a fourfold excess was sufficient to com- 
pete efficiently with SP3(1-16) for binding. Most important, 
design peptides with anchor spacing i, i+ 9 compete best (F9), 
although peptides with the pattern i, i+8 (F8) and i, i+10 
(F10) are powerful competitors, too. The relevance of the 
NH2-terminal anchor is shown by a sharper decline in com- 
petition after substitution of leucine by alanine as compared 
with substitution of phenylalanine. Significantly, leaving the 
anchor residues in their original distance (i, i+ 8) and placing 
three proline residues into the region between leads to a con- 
siderable loss of affinity and emphasizes  the importance of 
folding propensities of amino acid side chains located between 
the putative anchor positions. 
Discussion 
As a whole, the sequence analysis of DRl-associated self- 
peptides  reveals some  similarities  to  the  analyses  of en- 
dogenously processed peptides of class I HLA-A2.1  (8) and 
HLA-B27 (9), or to murine class II molecules I-A  b and I-E  b 
(11). The strong accumulation of isoleucine, leucine, and tyro- 
sine in positions 1 and 2 of the pool sequencing favors the 
view that these amino acids may function as anchor residues 
that are necessary for making contact with the DR1 peptide- 
binding groove. Since all three hydrophobic residues are pre- 
dominant in both positions the NH2-terminal anchor of 
DR1 might be out of frame, having variable distance from 
the NH2  terminus. Alternatively, leucine, isoleucine,  and 
tyrosine might form a double anchor at positions 1 and 2. 
Leucine was also found as a putative anchor of self-peptides 
eluted from dass I HLA-A2.1, but exclusively in position 2 
with an invariant distance from the NH2 terminus (8). In 
the case of HLA-B27, nearly all of the sequenced self-peptides 
exhibited an arginine anchor at position 2 and, comparable 
with our findings, in 7 of the 11 peptides arginine reappeared 
in position 1 (9). Additionally, our result is in contrast to 
the routine self-peptide analogues, where no invariant residues 
could be found (11). More important, human class II self- 
peptides are considerably larger than their class I counter- 
parts. Whereas class I peptides are octa- or nonamers (8, 9), 
the majority of our class II peptides contains not more than 
16 residues. This is in accordance with murine self-peptides 
that proved to be 13-17  amino acids long (11). 
Common Hydrophobic Motif of DRl-associated Self- and For- 
eign Peptides.  The alignment of DRl-restricted T cell epi- 
topes according to their putative NH2-terminal  hydrophobic 
anchor shows two parallels to our pool sequence analysis (Table 
1): (a) similarly, bulky aliphatic residues as isoleucine, leu- 
cine,  valine,  and aromatic tyrosine residues  appear  in the 
NH2-terminal  anchor  position,  their  importance  being 
tested in a recent cellular binding assay with biotinylated de- 
rivatives (14); and (b) close to the putative first anchor most 
often stands another bulky hydrophobic amino acid that might 
function as a coanchor, fitting into one of the postulated hy- 
drophobic pockets of DR1 (12). Two consecutive hydrophobic 
residues  close to the NH2-terminus reoccur in SP3 (Ile-2, 
Leu-3). This might explain the higher binding affinity of SP3 
compared with IM(18-29), which lacks a comparable coan- 
chor. Besides that, the alignment in Table 1 strengthens the 
importance of a COOH-terminal hydrophobic residue in po- 
sition i, i+8 or i+9 relative to the NH2-terminal anchor. 
The exact spacing seems to depend on the portion of helical 
conformation of the core-region bordered by the two anchors. 
Peptides with high helical propensity, as the polyalanine-based 
SP3 analogues,  are rather compressed, their anchor residues 
being spaced according to i, i+9. The same seems to be true 
with the foreign T  cell epitope circumsporozoite protein 
(381-393)  (Table 1).  Peptides,  as  influenza  hemagglu- 
tinin(18-29) or IM(18-29),  with lower helical  propensity 
might adopt a slightly more extended conformation; thereby 
the distance  of the contact sites is reduced to i, i+ 8.  Our 
self-peptide SP3 also has a core region with considerable he- 
lical propensity and sticks  to the same i, i+ 8 rule.  Helix- 
destabilizing prolines defold a previously helical peptide core, 
thereby reducing the affinity considerably (Fig. 3). Neverthe- 
less, binding peptides seem to have some conformational 
freedom, due to a higher degree of folding flexibility in the 
binding groove of class II compared with class I molecules, 
no matter whether self- or non-self-antigens are involved. The 
immunological relevance of the putative hydrophobic two- 
residue contact motif may be that primarily hydrophobic 
regions, normally located in the interior of folded protein 
antigens and therefore "invisible" to the B cell receptor, be- 
come immunogenic, provided that a stringent selection by 
unfolding, processing,  and  proper targeting  makes them 
"visible" for the helper T  cell receptor. 
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